Apoptosis

Overview Forums Topics
Ask our Community
Members
News
This Week in Cancer Discovery
In Cancer Discovery this week, researchers at Genentech and the BC Cancer Agency report that the p27 phosphatase PPM1H is implicated in trastuzumab resistance in some breast cancer patients.
Spectrum Pharmaceuticals Completes Enrollment in the Belinostat Pivotal Trial for Relapsed/Refractory Peripheral T ...
HENDERSON, Nev.--(BUSINESS WIRE)--SPECTRUM PHARMACEUTICALS COMPLETES ENROLLMENT IN THE BELINOSTAT PIVOTAL TRIAL FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA
Dove Medical Press Announces Dr Chulhee Choi as the Editor-in-Chief of Nanobiosensors in Disease Diagnosis
Dr Chulhee Choi has been appointed Editor-in-Chief of the new open access journal Nanobiosensors in Disease Diagnosis, published by Dove Medical Press. (PRWeb September 28, 2011) Read the full story at http://www.prweb.com/releases/2011/9/prweb8811131.htm
Cancer Biologist Maureen Murphy Joins The Wistar Institute
The Wistar Institute announces Maureen Murphy, Ph.D., will join the Institute as a professor in the Molecular and Cellular Oncogenesis Program of the Institute's Cancer Center.
Dove Medical Press Announces Dr Chulhee Choi as the Editor-in-Chief of Nanobiosensors in Disease Diagnosis
Dr Chulhee Choi has been appointed Editor-in-Chief of the new open access journal Nanobiosensors in Disease Diagnosis, published by Dove Medical Press.Auckland, New Zealand (PRWEB) September 28, 2011 Dove Medical Press has announced the appointment of Pro